Shopping Cart
- Remove All
![TargetMol](https://newstatic.targetmol.com/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | Acotiamide is an orally active, selective and reversible acetylcholinesterase ( AChE ) inhibitor, with IC 50 of 1.79 μM. Acotiamide is a gastroprokinetic agent that enhances gastric contractility and accelerates delayed gastric emptying. Acotiamide has the potential for the research of functional dyspepsia involving gastric motility dysfunction and intestinal inflammatory [1] [2] [3]. |
In vitro | Acotiamide (10, 30, 100 μM; 1 hour) significantly reduces IκB-α phosphorylation expression levels in LPS- and MCP-1-activated macrophage cell lines, specifically NR8383, as observed in Cell Viability Assays [1]. This treatment resulted in a noticeable decrease in the production of both TNF-α and IL-6 in these stimulated cells. |
In vivo | Acotiamide demonstrates a dose-dependent enhancement in postprandial gastric motility indices when administered either intravenously (0.3, 1, 3 mg/kg) or orally (3, 10, 30 mg/kg) [2]. A single intravenous dose (0.83 mg/kg) of acotiamide significantly inhibits acetylcholinesterase (AChE) activity in the rat stomach, with an IC 50 value of 1.79 μM, thereby potentially improving functional dyspepsia [3]. These findings were observed in experiments involving male mongrel dogs weighing 9-11 kg and male beagle dogs weighing 9.6-12.9 kg for the gastric motility study [2], and male Sprague-Dawley rats aged 6-7 weeks for the AChE inhibition study [3]. The results indicate acotiamide's effectiveness in increasing postprandial gastric motility and inhibiting AChE in the stomach, evidenced by detailed animal models and specific dosage administrations. |
Molecular Weight | 450.55 |
Formula | C21H30N4O5S |
Cas No. | 185106-16-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.